Date: Thursday, March 17, 2022 12:00 pm - 1:00 pm
Categories: TraCS-sponsored *

Inclusive Science Program Series - Semblie: Introduction and New Feature Demo

Join a live training session for Semblie, a free platform for developing digital health interventions. Semblie was specifically designed with the needs of public health researchers and practitioners in mind. This web-based platform makes it easy to create interactive decision aids and tailored health education tools. This session will introduce the Semblie platform and the types of content that can be designed. We will also demo the new drag-and-drop feature for designing slides in Semblie.

This session is for anyone interested in using Semblie for public health interventions or research. No prior experience with Semblie is required for this session. For more information about Semblie, please visit here.

Semblie was developed by RTI International with funding from NC TraCS.

Register


Presenters:

Laura Wagner
MPH, Health Behavior / Health Education, University of North Carolina
BA, Cognitive Science, University of Virginia
Laura Wagner, a research public health analyst with RTI's Center for Communication Science, has over a decade of professional experience in health
communication and public health research. Her expertise includes patient-centered outcomes, cancer prevention and care, digital and social media
strategy, and virtual and augmented reality. She is skilled at both quantitative and qualitative research methods, including the design, conduct, and
analysis of surveys, focus groups, in-depth interviews, behavioral measures, and web analytics.

Juliana Hoover
BA, Linguistics, Duke University
Juliana Hoover is a public health analyst in RTI's Center for Communication Science. She has experience supporting both quantitative
and qualitative health communication studies, including interviews, focus groups, surveys, text analysis, literature reviews, and
usability testing studies. She has supported projects for a range of clients including the Food and Drug Administration (FDA), the Centers for Disease
Control and Prevention (CDC), and the National Institutes of Health (NIH).

For any questions regarding this event, please email Laura Villa-Torres at This email address is being protected from spambots. You need JavaScript enabled to view it..